DK1047449T3 - Immunologiske præparater og anvendelse deraf til forbigående ændring af myelin i centralnervesystemet hos pattedyr for at fremme neuronal regenerering - Google Patents
Immunologiske præparater og anvendelse deraf til forbigående ændring af myelin i centralnervesystemet hos pattedyr for at fremme neuronal regenereringInfo
- Publication number
- DK1047449T3 DK1047449T3 DK98949847T DK98949847T DK1047449T3 DK 1047449 T3 DK1047449 T3 DK 1047449T3 DK 98949847 T DK98949847 T DK 98949847T DK 98949847 T DK98949847 T DK 98949847T DK 1047449 T3 DK1047449 T3 DK 1047449T3
- Authority
- DK
- Denmark
- Prior art keywords
- nervous system
- central nervous
- neuronal regeneration
- mammalian central
- promote neuronal
- Prior art date
Links
- 230000001052 transient effect Effects 0.000 title abstract 2
- 230000004075 alteration Effects 0.000 title 1
- 210000003169 central nervous system Anatomy 0.000 title 1
- 230000001900 immune effect Effects 0.000 title 1
- 230000009689 neuronal regeneration Effects 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 102000000989 Complement System Proteins Human genes 0.000 abstract 2
- 108010069112 Complement System Proteins Proteins 0.000 abstract 2
- 102000006386 Myelin Proteins Human genes 0.000 abstract 2
- 108010083674 Myelin Proteins Proteins 0.000 abstract 2
- 210000005012 myelin Anatomy 0.000 abstract 2
- 208000016192 Demyelinating disease Diseases 0.000 abstract 1
- 206010012305 Demyelination Diseases 0.000 abstract 1
- 230000009693 chronic damage Effects 0.000 abstract 1
- 210000002569 neuron Anatomy 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000008929 regeneration Effects 0.000 abstract 1
- 238000011069 regeneration method Methods 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2219683 CA2219683A1 (en) | 1997-10-28 | 1997-10-28 | Immunological composition and its method of use to transiently disrupt mammalian central nervous system myelin to promote neuronal regeneration |
| CA2251410 | 1998-10-16 | ||
| PCT/CA1998/000997 WO1999021581A1 (en) | 1997-10-28 | 1998-10-28 | Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1047449T3 true DK1047449T3 (da) | 2004-01-26 |
Family
ID=25679779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98949847T DK1047449T3 (da) | 1997-10-28 | 1998-10-28 | Immunologiske præparater og anvendelse deraf til forbigående ændring af myelin i centralnervesystemet hos pattedyr for at fremme neuronal regenerering |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US6548061B1 (de) |
| EP (1) | EP1047449B1 (de) |
| JP (1) | JP2001521008A (de) |
| AT (1) | ATE249241T1 (de) |
| AU (1) | AU748143B2 (de) |
| DE (1) | DE69818106T2 (de) |
| DK (1) | DK1047449T3 (de) |
| ES (1) | ES2210829T3 (de) |
| IL (2) | IL135799A0 (de) |
| PT (1) | PT1047449E (de) |
| WO (1) | WO1999021581A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000064473A1 (en) * | 1999-04-28 | 2000-11-02 | University Of British Columbia | Composition for neuronal regeneration comprising myelin-specific antibodies and complement proteins |
| GB0103174D0 (en) * | 2001-02-08 | 2001-03-28 | Smithkline Beecham Plc | Novel method of treatment |
| TWI323265B (en) * | 2002-08-06 | 2010-04-11 | Glaxo Group Ltd | Antibodies |
| GB0306309D0 (en) | 2003-03-19 | 2003-04-23 | Glaxo Group Ltd | Method of treatment |
| EP2698166B1 (de) | 2006-10-10 | 2015-09-30 | Regenesance B.V. | Komplementhemmung für verbesserte Nervenregeneration |
| PH12013501201A1 (en) * | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| UY35468A (es) | 2013-03-16 | 2014-10-31 | Novartis Ag | Tratamiento de cáncer utilizando un receptor quimérico de antígeno anti-cd19 |
| US10058471B2 (en) * | 2014-02-21 | 2018-08-28 | William M. Vaughan | System and method of using hyperbaric oxygen therapy for treating concussive symptoms and musculoskeletal injuries and for pre-treatment to prevent damage from injuries |
| PL3888674T3 (pl) | 2014-04-07 | 2024-09-23 | Novartis Ag | Leczenie nowotworu złośliwego z zastosowaniem chimerycznego receptora antygenowego anty-CD19 |
| PL3280729T3 (pl) | 2015-04-08 | 2022-08-22 | Novartis Ag | Terapie cd20, terapie cd22 i terapie skojarzone komórką eksprymującą chimeryczny receptor antygenowy (car) cd19 |
| AU2017341047B2 (en) | 2016-10-07 | 2024-10-10 | Novartis Ag | Chimeric antigen receptors for the treatment of cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991002003A1 (en) * | 1989-08-04 | 1991-02-21 | Board Of Regents, The University Of Texas System | Methods and compositions; purified preparation of neural progenitor regulatory factor |
| US6020140A (en) * | 1991-08-09 | 2000-02-01 | Washington University | Autoantibodies and their targets in the diagnosis of peripheral neuropathies |
| EP0659083B1 (de) * | 1992-06-12 | 1999-12-22 | Cephalon, Inc. | Vorbeugung und behandlung der peripheren neuropathie |
| US5714385A (en) * | 1995-05-10 | 1998-02-03 | Genentech, Inc. | Media for culturing schwann cells |
| US6228598B1 (en) * | 1998-10-02 | 2001-05-08 | Washington University | Antibodies to heparan sulfate glycosaminoglycans in the diagnosis of polyneuropathies |
-
1998
- 1998-10-28 IL IL13579998A patent/IL135799A0/xx active IP Right Grant
- 1998-10-28 WO PCT/CA1998/000997 patent/WO1999021581A1/en active IP Right Grant
- 1998-10-28 JP JP2000517739A patent/JP2001521008A/ja active Pending
- 1998-10-28 DE DE69818106T patent/DE69818106T2/de not_active Expired - Lifetime
- 1998-10-28 US US09/181,719 patent/US6548061B1/en not_active Expired - Fee Related
- 1998-10-28 PT PT98949847T patent/PT1047449E/pt unknown
- 1998-10-28 US US09/530,234 patent/US6969516B1/en not_active Expired - Fee Related
- 1998-10-28 ES ES98949847T patent/ES2210829T3/es not_active Expired - Lifetime
- 1998-10-28 EP EP98949847A patent/EP1047449B1/de not_active Expired - Lifetime
- 1998-10-28 AU AU96179/98A patent/AU748143B2/en not_active Ceased
- 1998-10-28 DK DK98949847T patent/DK1047449T3/da active
- 1998-10-28 AT AT98949847T patent/ATE249241T1/de not_active IP Right Cessation
-
2000
- 2000-04-24 IL IL135799A patent/IL135799A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US6548061B1 (en) | 2003-04-15 |
| AU9617998A (en) | 1999-05-17 |
| ATE249241T1 (de) | 2003-09-15 |
| ES2210829T3 (es) | 2004-07-01 |
| WO1999021581A1 (en) | 1999-05-06 |
| PT1047449E (pt) | 2004-04-30 |
| IL135799A0 (en) | 2001-05-20 |
| IL135799A (en) | 2011-01-31 |
| AU748143B2 (en) | 2002-05-30 |
| JP2001521008A (ja) | 2001-11-06 |
| US6969516B1 (en) | 2005-11-29 |
| EP1047449A1 (de) | 2000-11-02 |
| EP1047449B1 (de) | 2003-09-10 |
| DE69818106D1 (de) | 2003-10-16 |
| DE69818106T2 (de) | 2004-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE159429T1 (de) | Methode zum überbringen von agenzien an zielzellen | |
| Coulter et al. | Simplified preparation of rabbit Fab fragments | |
| DK1047449T3 (da) | Immunologiske præparater og anvendelse deraf til forbigående ændring af myelin i centralnervesystemet hos pattedyr for at fremme neuronal regenerering | |
| DE69309472D1 (de) | Fusionsproteine von monomeren und dimeren von antikörperfragmenten | |
| DK1194167T3 (da) | Immunoterapi af autoimmune sygdomme under anvendelse af B-cellespecifikke antistoffer | |
| CY1107821T1 (el) | Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c | |
| AR001811A1 (es) | Anticuerpos anti-icam-1 modificados y su uso en eltratamiento de inflamaciones | |
| ATE248605T1 (de) | Für e-selectin und p-selectin spezifische kreuzreaktive monoklonale antikörper | |
| ATE112687T1 (de) | Mutanten des hiv-1 hüllproteins mit fehlenden hypervariabelen domänen. | |
| MX7235E (es) | Procedimiento para preparar una solucion inyectable intravenosamente de globulina de suero inmune | |
| ATE133866T1 (de) | Antikörper-heterokonjugate zur regulation der lymphozytenaktivität | |
| DE3854194D1 (de) | Monoklonale antikörper gegen glykosyliertes albumin, hybride zellinien, die diese antikörper produzieren, sowie deren verwendung. | |
| EA200000449A1 (ru) | Модифицированные витамины к-зависимые полипептиды | |
| NL300372I1 (nl) | Hybride immunoglobulinen voor gebruik bij therapeutische werkwijzen | |
| DE69939327D1 (de) | Funktionelle antagonisten von hedgehog-aktivität | |
| DE69028513D1 (de) | Träger zur bindung von antiphospholipid-antikörpern, diese antikörper verwendender immunotest und kit dafür | |
| DE69434384D1 (de) | Metalkomplexbildner | |
| ATE234111T1 (de) | Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung | |
| DK407488A (da) | Fremgangsmaade til behandling af overskud af jern | |
| ATE410514T1 (de) | Calciumbindende rekombinante antikörper gegen protein c | |
| DE69330352D1 (de) | Mittel und methoden zur verbesserung der keratinocytenadhäsion an der haut | |
| DE68905342D1 (de) | Verwendung von minoxidil zur wundheilung. | |
| DE58906338D1 (de) | Kombination von Angiotensin-Converting-Enzyme-Hemmern mit Kaliumkanal-Modulatoren sowie deren Verwendung in Arzneimitteln. | |
| CA2253078A1 (en) | Immunological composition and its method of use to transiently disrupt mammalian central nervous system myelin to promote neuronal regeneration | |
| Colborne | Two experiments on methods of training children in road safety |